about
Dendritic cell rehab: new strategies to unleash therapeutic immunity in ovarian cancer.TET1 inhibits cell proliferation by inducing RASSF5 expression.Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer.A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Management of relapsed ovarian cancer: a review
@ast
Management of relapsed ovarian cancer: a review
@en
Management of relapsed ovarian cancer: a review
@nl
type
label
Management of relapsed ovarian cancer: a review
@ast
Management of relapsed ovarian cancer: a review
@en
Management of relapsed ovarian cancer: a review
@nl
prefLabel
Management of relapsed ovarian cancer: a review
@ast
Management of relapsed ovarian cancer: a review
@en
Management of relapsed ovarian cancer: a review
@nl
P2860
P3181
P1433
P1476
Management of relapsed ovarian cancer: a review
@en
P2093
Gonzalo H Giornelli
P2860
P2888
P3181
P356
10.1186/S40064-016-2660-0
P407
P577
2016-01-01T00:00:00Z
P6179
1042136028